Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
6.03
-0.73 (-10.80%)
Dec 11, 2025, 4:00 PM EST - Market closed
Aclarion Revenue
Aclarion had revenue of $18.94K in the quarter ending September 30, 2025, with 31.48% growth. This brings the company's revenue in the last twelve months to $67.48K, up 36.91% year-over-year. In the year 2024, Aclarion had annual revenue of $45.72K, down -39.36%.
Revenue (ttm)
$67.48K
Revenue Growth
+36.91%
P/S Ratio
58.34
Revenue / Employee
$11,247
Employees
6
Market Cap
4.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.72K | -29.68K | -39.36% |
| Dec 31, 2023 | 75.40K | 14.96K | 24.75% |
| Dec 31, 2022 | 60.44K | 152.00 | 0.25% |
| Dec 31, 2021 | 60.29K | 11.64K | 23.93% |
| Dec 31, 2020 | 48.65K | 21.76K | 80.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ACON News
- 9 days ago - Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - GlobeNewsWire
- 7 weeks ago - Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - GlobeNewsWire
- 2 months ago - Aclarion to Present at the LD Micro Main Event XIX - Newsfile Corp
- 6 months ago - Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum - GlobeNewsWire
- 7 months ago - Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - GlobeNewsWire
- 7 months ago - Aclarion Announces Texas Back Institute as New CLARITY Trial Site - GlobeNewsWire
- 8 months ago - Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - GlobeNewsWire
- 8 months ago - Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - GlobeNewsWire